These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7433767

  • 21. [The content of catecholamines in the adrenergic plexuses of the spleen and intestines during cold and emotional stresses].
    Dib J, Lapsha VI, Gurin VN.
    Neirofiziologiia; 1990; 22(3):347-54. PubMed ID: 2398930
    [Abstract] [Full Text] [Related]

  • 22. Tranylcypromine, but not moclobemide, prolongs the inhibitory action of dopamine on midbrain dopaminergic neurons: an in vitro electrophysiological study.
    Mercuri NB, Federici M, Marinelli S, Bernardi G.
    Synapse; 2000 Sep 01; 37(3):216-21. PubMed ID: 10881043
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The phenyl rings of tricyclic antidepressants and related compounds as determinants of the potency of inhibition of the amine pumps in adrenergic neurons of the rabbit aorta and in rat cortical synaptosomes.
    Maxwell RA, Ferris RM, Burcsu J, Woodward EC, Tang D, Williard K.
    J Pharmacol Exp Ther; 1974 Dec 01; 191(3):418-30. PubMed ID: 4427288
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Ultrastructural and immunohistologic characterization of guanethidine-induced destruction of peripheral sympathetic neurons.
    Schmidt RE, Summerfield AL, Hickey WF.
    J Neuropathol Exp Neurol; 1990 Mar 01; 49(2):150-67. PubMed ID: 2307981
    [Abstract] [Full Text] [Related]

  • 27. [Immunochemical and chemical desympathization].
    Borisov MM, Mukhammedov A, Doronin PP, Rodionov IM, Iarygin VN.
    Usp Fiziol Nauk; 1977 Mar 01; 8(1):74-90. PubMed ID: 331719
    [No Abstract] [Full Text] [Related]

  • 28. Some characteristics of the adrenergic neurone blocking action of dehydroemetine.
    Gulati OD, Makol R, Shah DS.
    Br J Pharmacol; 1973 Jun 01; 48(2):314-7. PubMed ID: 4733732
    [Abstract] [Full Text] [Related]

  • 29. Interactions of drugs with adrenergic neurons.
    Costa E, Boullin DJ, Hammer W, Vogel W, Brodie BB.
    Pharmacol Rev; 1966 Mar 01; 18(1):577-97. PubMed ID: 5904171
    [No Abstract] [Full Text] [Related]

  • 30. Possible role of adrenergic mechanisms in the systemic anti-inflammatory activity of acetic acid in rats.
    Atkinson DC, Hicks R.
    Eur J Pharmacol; 1974 May 01; 26(2):158-65. PubMed ID: 4153004
    [No Abstract] [Full Text] [Related]

  • 31. Evidence that guanethidine does not block adrenergic nerves by acting as a false transmitter.
    Morgan DH, Oates JA, Shand DG.
    Br J Pharmacol; 1970 May 01; 39(1):186P-187P. PubMed ID: 4315986
    [No Abstract] [Full Text] [Related]

  • 32. A new method of destroying adrenergic nerves in adult animals using guanethidine.
    Burnstock G, Evans B, Gannon BJ, Heath JW, James V.
    Br J Pharmacol; 1971 Oct 01; 43(2):295-301. PubMed ID: 5158199
    [Abstract] [Full Text] [Related]

  • 33. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
    Hancock AA, Buckner SA, Giardina WJ, Brune ME, Lee JY, Morse PA, Oheim KW, Stanisic DS, Warner RB, Kerkman DJ.
    J Pharmacol Exp Ther; 1995 Mar 01; 272(3):1160-9. PubMed ID: 7891328
    [Abstract] [Full Text] [Related]

  • 34. Mechanism of nicotine-induced relaxation in the porcine basilar artery.
    Zhang W, Edvinsson L, Lee TJ.
    J Pharmacol Exp Ther; 1998 Feb 01; 284(2):790-7. PubMed ID: 9454828
    [Abstract] [Full Text] [Related]

  • 35. Dual actions of guanethidine on amine uptake mechanisms in adrenergic neurons.
    Shore PA, Giachetti A.
    Biochem Pharmacol; 1966 Jul 01; 15(7):899-903. PubMed ID: 5338640
    [No Abstract] [Full Text] [Related]

  • 36. Regulation of c-Fos and NGF1-A by antidepressant treatments.
    Morinobu S, Strausbaugh H, Terwilliger R, Duman RS.
    Synapse; 1997 Apr 01; 25(4):313-20. PubMed ID: 9097389
    [Abstract] [Full Text] [Related]

  • 37. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H.
    J Pharmacol Exp Ther; 1994 Mar 01; 268(3):1432-43. PubMed ID: 8138956
    [Abstract] [Full Text] [Related]

  • 38. [Reverse transsynaptic regulation of noradrenaline-H3 uptake in chronic sympathetic denervation].
    Kurbanova GD, Manukhin BN.
    Fiziol Zh SSSR Im I M Sechenova; 1983 Sep 01; 69(9):1164-9. PubMed ID: 6641995
    [Abstract] [Full Text] [Related]

  • 39. Antagonism of the adrenergic neurone blocking action of guanethidine by certain antidepressant and antihistamine drugs.
    Gokhale SD, Gulati OD, Udwadia BP.
    Arch Int Pharmacodyn Ther; 1966 Apr 01; 160(2):321-9. PubMed ID: 4380978
    [No Abstract] [Full Text] [Related]

  • 40. Effect of metabolic poisons and digoxin on the adrenergic neurone blocking action of guanethidine.
    Jaykar S, Gulati OD.
    Indian J Physiol Pharmacol; 1972 Jan 01; 16(1):75-80. PubMed ID: 5025968
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.